L73

N-butylglycyl-4-tert-butyl-D-phenylalanyl-3-methoxy-N-methyl-L-phenylalaninamide

Created:	2022-02-28
Last modified:	2022-10-05

Find Related PDB Entry
1 entries where L73 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	82
Chiral Atom Count	2
Bond Count	83
Aromatic Bond Count	12

2D diagram of L73

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-butylglycyl-4-tert-butyl-D-phenylalanyl-3-methoxy-N-methyl-L-phenylalaninamide
Systematic Name (OpenEye OEToolkits)	(2~{R})-2-[2-(butylamino)ethanoylamino]-3-(4-~{tert}-butylphenyl)-~{N}-[(2~{S})-3-(3-methoxyphenyl)-1-(methylamino)-1-oxidanylidene-propan-2-yl]propanamide
Formula	C₃₀ H₄₄ N₄ O₄
Molecular Weight	524.695
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	COc1cc(CC(NC(=O)C(Cc2ccc(cc2)C(C)(C)C)NC(=O)CNCCCC)C(=O)NC)ccc1
SMILES	CACTVS	3.385	CCCCNCC(=O)N[CH](Cc1ccc(cc1)C(C)(C)C)C(=O)N[CH](Cc2cccc(OC)c2)C(=O)NC
SMILES	OpenEye OEToolkits	2.0.7	CCCCNCC(=O)NC(Cc1ccc(cc1)C(C)(C)C)C(=O)NC(Cc2cccc(c2)OC)C(=O)NC
Canonical SMILES	CACTVS	3.385	CCCCNCC(=O)N[C@H](Cc1ccc(cc1)C(C)(C)C)C(=O)N[C@@H](Cc2cccc(OC)c2)C(=O)NC
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCCCNCC(=O)N[C@H](Cc1ccc(cc1)C(C)(C)C)C(=O)N[C@@H](Cc2cccc(c2)OC)C(=O)NC
InChI	InChI	1.03	InChI=1S/C30H44N4O4/c1-7-8-16-32-20-27(35)33-26(18-21-12-14-23(15-13-21)30(2,3)4)29(37)34-25(28(36)31-5)19-22-10-9-11-24(17-22)38-6/h9-15,17,25-26,32H,7-8,16,18-20H2,1-6H3,(H,31,36)(H,33,35)(H,34,37)/t25-,26+/m0/s1
InChIKey	InChI	1.03	VWEUUVZMTLGMMV-IZZNHLLZSA-N

Related Resource References

Resource Name	Reference
PubChem	165180702

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.